Role of GSTT1 deletion in DNA oxidative damage by exposure to polycyclic aromatic hydrocarbons in humans

International Journal of Cancer

Volumn 120, Issue 11, 2007, Pages 2499-2503

  Garte, Seymour ^a   Taioli, Emanuela ^a   Popov, Todor ^b   Kalina, Ivan ^c   Sram, Radim ^d   Farmer, Peter ^e  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^c P J AFÁRIK UNIVERSITY   (Slovakia)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Biological markers; Cohort study; Susceptibility

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; DNA DAMAGE; DRIVER; ENVIRONMENTAL EXPOSURE; GENE; GENE DELETION; GSTT1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; POLICE; PRIORITY JOURNAL;

DNA DAMAGE; GLUTATHIONE TRANSFERASE; HUMANS; OXIDATIVE STRESS; POLYCYCLIC COMPOUNDS;

EID: 34247361955     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22477     Document Type: Article

References (47)

1. Garte S. Metabolic susceptibility genes as cancer risk factors: time for a reassessment? Cancer Epidemiol Biomarkers Prev 2001;10:1233-7.
2. Stücker I, Boffetta P, Anttila S, Benhamou S, Hirvonen A, London S, Taioli E. Lack of interaction between asbestos exposure and glutathione S-transferase M1 and T1 genotype in lung carcinogenesis. Cancer Epidemiol Biomarkers Prev 2001;10:1253-8.
3. Taioli E, Garte S. Genetic susceptibility to environmental carcinogens. Recent Res Dev Cancer 1999;1:57-67.
4. Vineis P, Malats N, Lang M, D'Errico A, Caporaso N, Cuzick J, Boffetta P. Metabolic polymorphisms and susceptibility to cancer. Lyon, France: IARC, 1999.151-60.
5. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88.
6. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-43.
7. Engel LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q, Boffetta P, Vineis P, Autrup H, Bell DA, Branch RA, Brockmoller J, et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002;156:95-109.
8. Hashibe M, Brennan P, Strange RC, Bhisey R, Cascorbi I, Lazarus P. Oude Ophuis MB, Benhamou S, Foulkes WD, Katoh T, Coutelle C, Romkes M, et al. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2003;12:1509-17.
9. Ford JG, Li Y, O'Sullivan MM, Demopoulos R, Garte S, Taioli E, Brandt-Rauf PW. Glutathione S-transferase M1 (GSTM1) polymorphism and lung cancer risk in African-Americans. Carcinogenesis 2000;21:1971-5.
10. Hung RJ, Boffetta P, Brockmöller J, Butkiewicz D, Cascorbi I, Clapper ML, Garte S, Haugen A, Hirvonen A, Anttila S, Kalina I, Le Marchand L, et al. CYP1A1 and GSTM1 Genetic polymorphisms and lung cancer risk in Caucasian nonsmokers: a pooled analysis. Carcinogenesis 2003;24:875-82.
11. Sorensen M, Autrup H, Tjonneland A, Overvad K, Raaschou-Nielsen O. Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer. Int J Cancer 2004;110:219-24.
12. Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S. Boffetta P, Cote ML, Dialyna IA, Dolzan V, Filiberti R, Garte S, Hirvonen A, et al. Meta and pooled analysis of GSTT and lung cancer: a HuGE-GSEC review. Am J Epidemiol 2006;164(11):1027-42.
13. Buzio L, De Palma G, Mozzoni P, Tondel M, Buzio C, Franchini I, Axelson O, Mutti A. Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals. Occup Environ Med 2003;60:789-93.
14. Garcia-Closas M, Kelsey KT, Hankinson SE, Spiegelman D, Springer K, Willett WC, Speizer FE, Hunter DJ. Glutathione S-transferase μ and θ polymorphisms and breast cancer susceptibility. J Natl Cancer Inst 1999;91:1960-4.
15. Kim W-J, Kim H, Kim C-H, Lee MS, Oh BR, Lee HM, Katoh T. GSTT1-null genotype is a protective factor against bladder cancer. Urology 2002;60:913-18.
16. Rebbeck TR, Walker AH, Jaffe JM, White DL, Wein AJ, Malkowicz SB. Glutathione S-transferase-μ (GSTM1) and -θ (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999;8:283-7.
17. Katoh T, Inatomi H, Kim H, Yang M, Matsumoto T, Kawamoto T. Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer. Cancer Lett 1998;132:147-52.
18. Risch A, Wikmana H, Thiel S, Schmezera P, Edler L, Drings P, Dienemann H, Kayser K, Schulz V, Spiegelhalder B, Bartsch H. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics 2001;11:757-64.
19. Infante-Rivard C, Weinberg CR, Guiguet M. Xenobiotic-metabolizing genes and small-for-gestational-age births interaction with maternal smoking. Epidemiology 2006;17:38-46.
20. Rahman SH, Nanny C, Ibrahim K, O'Reilly D, Larvin M, Kingsnorth AJ, Mcmahon MJ. Genetic polymorphisms of GSTT1, GSTM1, GSTP1, MnSOD, and catalase in nonhereditary chronic pancreatitis: evidence of xenobiotic stress and impaired antioxidant capacity. Dig Dis Sci 2005;50:1376-83.
21. Thier R, Taylor JB, Pemble SE, Humphreys WG, Persmark M, Ketterer B, Guengerich FP. Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA1535 leads to base-pair mutations upon exposure to dihalomethanes. Proc Natl Acad Sci USA 1993;90:8576-80.
22. Sherratt PJ, Pulford DJ, Harrison DJ, Green T, Hayes JD. Evidence that human class θ glutathione S-transferase T1-1 can catalyse the activation of dichloromethane, a liver and lung carcinogen in the mouse. Comparison of the tissue distribution of GST T1-1 with that of classes α, μ and π GST in human. Biochem J 1997;326:837-46.
23. Hallier E, Schroder KR, Asmuth K, Dommermuth A, Aust B, Goergens HW. Metabolism of dichloromethane (methylene chloride) to formaldehyde in human erythrocytes: influence of polymorphism of glutathione transferase θ (GST T1-1). Arch Toxicol 1994;68:423-7.
24. DeMarini DM, Shelton ML, Warren SH, Ross TM, Shim JY, Richard AM, Pegram RA. Glutathione S-transferase-mediated induction of GC->AT transitions by halomethanes in Salmonella. Environ Mol Mutagen 1997;30:440-7.
25. London SJ, Yuan JM, Chung FL, Gao YT, Coetzee GA, Ross RK, Yu MC. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 2000;356:724-9.
26. Vineis P, Veglia F, Antilla S, Benhamou S, Butkievicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Ingelman-Sundberg M, Kihara M et al. CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 2003;104:650-7.
27. Keshava C, Divi RL, Whipkey DL, Frye BL, McCanlies E, Kuo M, Poirier MC, Weston A. Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene. Cancer Lett 2005;221:213-14.
28. Jourenkova-Mironova N, Mitrunen K, Bouchardy C, Dayer P, Benhamou S, Hirvonen A. High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res 2000;60:534-6.
29. Millikan RC, Pittman GS, Newman B, Tse CK, Selmin O, Rockhill B, Savitz D, Moorman PG, Bell DA. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:371-8.
30. Rojas M, Cascorbi I, Alexandrov K, Kriek E, Auburtin G, Mayer L, Kopp-Schneider A, Roots I, Bartsch H. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis 2000;21:35-41.
31. Teixeira JP, Gaspar J, Martinho G, Silva S, Rodrigues S, Mayan O, Martin E, Farmer PB, Rueff J. Aromatic DNA adduct levels in coke oven workers: correlation with polymorphisms in genes GSTP1, GSTM1, GSTT1 and CYP1A1. Mutat Res 2002;517:147-55.
32. Georgiadis P, Topinka J, Vlachodimitropoulos D, Stoikidou M, Gioka M, Stephanou G, Autrup H, Demopoulos NA, Katsouyanni K, Sram R, Kyrtopoulos SA. Interactions between CYP1A1 polymorphisms and exposure to environmental tobacco smoke in the modulation of lymphocyte bulky DNA adducts and chromosomal aberrations. Carcinogenesis 2005;26:93-101.
33. Palli D, Masala G, Peluso M, Gaspari L, Krogh V, Munnia A, Panico S, Saieva C, Tumino R, Vineis P, Garte S. The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects. Carcinogenesis 2004;25:577-84.
34. Farmer PB, Singh R, Kaur B, Sram RJ, Binkova B, Kalina I, Popov TA, Garte S, Taioli E, Gabelova A, Cebulska-Wasilewska A. Molecular epidemiology studies of carcinogenic environmental pollutants. Effects of polycyclic aromatic hydrocarbons (PAHs) in environmental pollution on exogenous and oxidative DNA damage. Mutat Res 2003;544:397-402.
35. Garte S, Taioli E, Raimondi S, Paracchini V, Binkova B, Kalina I, Popov TA, Gabelova A, Cebulska-Wasilewska A, Sram R, Farmer PB. Effects of metabolic genotypes on intermediary biomarkers in subjects exposed to PAHs. Results from the EXPAH study. Mutat Res 2005;153-4:247-51.
36. Taioli E, Sram RJ, Binkova B, Kalina I, Popov TA, Garte S, Farmer PB. Biomarkers of exposure to PAHs and their relationship with environmental factors. Mutat Res, in press.
37. Sorensen M, Autrup H, Hertel O, Wallin H, Knudsen LE, Loft S. Personal exposure to PM2.5 and biomarkers of DNA damage. Cancer Epidemiol Biomarkers Prev 2003;12:191-6.
38. Musarrat J, Arezina-Wilson J, Wani AA. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer A 1996;32:1209-14.
39. Singh R, McEwan M, Lamb JH, Santella RM, Farmer PB. An improved liquid chromatography/tandem mass spectrometry method for the determination of 8-oxo-7,8-dihydro-2′-deoxyguanosine in DNA samples using immunoaffinity column purification. Rapid Commun Mass Spectrom 2003;17:126-34.
40. Peluso M, Neri M, Margarino G, Mereu C, Munnia A, Ceppi M, Buratti M, Felletti R, Stea F, Quaglia R, Puntoni R, Taioli E, et al. Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa of cigarette smokers and interaction with metabolic gene polymorphisms. Carcinogenesis 2004;25:2459-65.
41. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K et al. Metabolic gene frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001;10:1239-48.
42. Tang YM, Green BL, Chen GF, Thompson PA, Lang NP, Shinde A, Lin DX, Tan W, Lyn-Cook BD, Hammons GJ, Kadlubar FF. Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls. Pharmacogenetics 2000;10:761-6.
43. Singh R, Kaur B, Kalina I, Popov TA, Georgieva T, Garte S, Binkova B, Sram RJ, Taioli E, Farmer PB. Effects of environmental pollution on endogenous oxidative DNA damage in humans. Mutat Res, in press.
44. Perera FP, Mooney LA, Stampfer M, Phillips DH, Bell DA, Rundle A, Cho S, Tsai W, Mal J, Blackwood A, Tang D. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis 2002;23:1641-6.
45. Landi S. Mammalian class 0 GST and differential susceptibility to carcinogens: a review. Mutat Res 2000;463:247-83.
46. Lodovici M, Luceri C, Guglielmi F, Bacci C, Akpan V, Fonnesu ML, Boddi V, Dolara P. Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and MEH. Cancer Epidemiol Biomarkers Prev 2004;13:1342-8.
47. Gallou C, Longuemaux S, Delomenie C, Mejean A, Martin N, Martinet S, Palais G, Bouvier R, Droz D, Krishnamoorthy R, Junien C, Beroud C et al. Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma. Pharmacogenetics 2001;11:521-35.